Urgent Need for Regulatory Oversight of Human Cells, Tissues, and Cellular and Tissue-Based Products

JAMA. 2024 May 2. doi: 10.1001/jama.2024.6834. Online ahead of print.
No abstract available

Plain language summary

This Viewpoint discusses the death of a patient caused by unregulated biological products and efforts to encourage federal government oversight of such products.